Cite
HARVARD Citation
Trifilio, S. et al. (2015). Filgrastim versus TBO‐filgrastim to reduce the duration of neutropenia after autologous hematopoietic stem cell transplantation: TBO, or not TBO, that is the question. Clinical transplantation. pp. 1128-1132. [Online].